GSKGLAXF
13F holders, Q3 2025 (September 30)2holders +1
1new positions
0sold out
$21.20avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding GSK PLC (GLAXF) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($63.8M) and Saranac Partners Ltd ($335K).
- Company
- GSK PLC
- CUSIP
- G3910J179
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $335K |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 15,768 shares bought and 144,154 shares sold, net −128,386 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Aristotle Capital Management, LLC | 0.12% | Reduce -4.6% | 3,007,852 | $63.8M |
| Saranac Partners Ltd | 0.07% | New | 15,768 | $335K |
"% of holder's portfolio" is GLAXF's weight in each manager's 13F, not the share of GSK PLC the manager owns.